Percio S. Gulko

Percio Gulko practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Percio Gulko's NPI, 1770609521, was assigned on March 22, 2007. Percio Gulko graduated from Federal University of Rio Grande do Sul School of Medicine in 1987. Percio Gulko holds New York license 223143.

Percio Gulko's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Percio Gulko also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Percio Gulko's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Percio Gulko to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Percio Gulko practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Percio Gulko's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Percio Gulko is licensed in New York.

CMS data shows 84 Medicare services from Percio Gulko across 3 procedure codes in 2024, all of them office visits, for 57 Medicare patients. Medicare paid $9,386 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Percio Gulko in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have arthritis, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Percio Gulko's median patient age at 57, with 69% women.

In 2024, Percio Gulko wrote 301 Medicare Part D claims for 46 patients. 75% of them were for generic drugs. CMS names the drug for 211 of them, across 11 drugs with 11 or more claims each, at $280,167 in total drug cost. In 2023, CMS named 200 claims across 9 drugs.

Percio Gulko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 26 papers to Percio Gulko, published from 2011 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Arthritis, Rheumatoid, Fibroblasts and Synoviocytes. Percio Gulko has published most often in bioRxiv. Percio Gulko's most frequent co-authors are Randie H. Kim, MD, PhD, Fadi El Salem, MD and Steven B. Abramson, MD.

CMS Open Payments shows 5 general payments to Percio Gulko from 2 drug and device companies in 2016. Consulting fees make up the largest share, 77% of the total. Pfizer Inc. paid the most, $3,502.

Percio Gulko graduated from Federal University of Rio Grande do Sul School of Medicine in 1987.